Abstract
To the Editor:
Allergic rhinitis (AR) is the most common chronic inflammatory disease, affecting an estimated 100 million Europeans (1).Despite a substantial burden on individuals, society and health economies (2), AR remains under-diagnosed, under-estimated (in terms of severity), and under-treated (3). Although effective and safe treatments exist, patients wait too long to seek medical advice, often preferring to self-manage at drug stores and at the pharmacy.
Allergic rhinitis (AR) is the most common chronic inflammatory disease, affecting an estimated 100 million Europeans (1).Despite a substantial burden on individuals, society and health economies (2), AR remains under-diagnosed, under-estimated (in terms of severity), and under-treated (3). Although effective and safe treatments exist, patients wait too long to seek medical advice, often preferring to self-manage at drug stores and at the pharmacy.
Original language | English |
---|---|
Pages (from-to) | 618-622 |
Number of pages | 5 |
Journal | Rhinology |
Volume | 58 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2020 |
Keywords
- Allergic rhinitis
- European Forum for Research & Education in Allergy & Airway Diseases (EUFOREA)
- treatment algorithm